21
Sep
2020
Tag: drug development
25
May
2020
Bionest
Coronavirus Impacts on Industry: Part 1
As the COVID-19 pandemic rages on, the effects of the virus are being felt not only by the global populace, but by the various sectors of the health care industry and those that support them.
13
Apr
2020
Bionest
FDA Finalizes Gene Therapy Guidelines and Adds New Draft Guidance on Orphan Drug Exclusivity
The field of gene and cell therapy is flourishing. How is the FDA responding?
30
Mar
2020
Bionest
New Research Findings — and Potential New Avenues for Drug Discovery — in Type 2 Diabetes
Could two proteins -- TRAP-alpha and adipsin -- provide new ways to treat diabetes?
2
Mar
2020
Bionest
New Treatment Options for Hemoglobin-Based Blood Disorders
Sickle cell disease is a group of inherited disorders that affects hemoglobin, the oxygen-carrying protein in red blood cells (RBCs), and causes these cells to distort in shape at low oxygen levels. This condition affects 1 in 500 Americans of African descent and 1 in 1,000-1,400 of Hispanic descent, as well as millions...
17
Feb
2020
Bionest
New Treatments for Alzheimer’s Disease? Maybe.
No new treatments for Alzheimer’s disease have been approved since 2003. What's on the horizon?
3
Feb
2020
Bionest
Nobel Prize in Medicine Goes to Oxygen-Sensing Research
How cells sense and adapt to oxygen availability plays an important role in anemia, cancer, stroke, infection, wound healing, and myocardial infarction.
23
Dec
2019
Bionest
The SMA Market: Assessing the Unknowns
Challenges and opportunities in the field of spinal muscular atrophy, including how new disease-modifying therapies are likely to change SMA’s course over time.
9
Dec
2019
Bionest
First Peanut Allergy Immunotherapeutic Recommended for FDA Approval
No standardized oral immunotherapeutics have existed for peanut allergies. Could this soon change?
2
Dec
2019